![]() Anecdotal use of topical steroid oral prophylaxis has been reported in patients with breast cancer. Topical steroids might reduce stomatitis incidence and severity, and the need for dose reductions and interruptions of everolimus. Stomatitis is a class effect associated with the inhibition of mTOR and is associated with everolimus therapy for breast cancer. 13 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.12 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.11 Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA.10 Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA.9 UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. ![]() 8 Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA.7 Cancer Treatment Centers of America, Atlanta, GA, USA.6 St Luke's Cancer Institute, Kansas City, MO, USA.5 Oncology Consultants PA, Department of Research, Houston, TX, USA.4 University of California Los Angeles School of Medicine, Los Angeles, CA, USA.3 Highlands Oncology Group, Fayetteville, AR.Electronic address: 2 Los Angeles Cancer Network, Los Angeles, CA, USA. 1 University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |